Dental Literature Watch · Trial · Implants
Local Minocycline Adds Short-Term Benefit in Non-Surgical Peri-Implantitis
TL;DR
- Peri-implantitis has no reliably effective non-surgical treatment — which is why an adjunct that works at all is worth reading about.
- Debridement plus 2% minocycline ointment at baseline and weeks 1, 2 and 3, versus debridement plus placebo.
- At 12 weeks: lower baseline-adjusted probing depths and less frequent bleeding on probing in the minocycline group.
- Lower levels of selected peri-implant pathogens at 8 weeks; differences less consistent by 12 weeks.
- Less early swelling at 3 weeks, but no difference in oral health-related quality of life.
- The authors themselves say the radiographic findings should be interpreted cautiously because the follow-up was too short.
The study
| Design | Multicentre, randomised, single-blind, placebo-controlled trial |
| Sample | 48 randomised; 46 in per-protocol analysis (22 test, 24 control) after two withdrawals |
| Intervention | Subgingival debridement + 2% minocycline HCl ointment at baseline, weeks 1, 2, 3 |
| Follow-up | 12 weeks |
| Clinical | Lower adjusted probing depth, less bleeding on probing in the test group |
| Microbiology | Lower selected pathogens at 8 weeks (p < 0.05); inconsistent at 12 weeks |
| Patient-reported | Less swelling at 3 weeks; no difference in quality of life |
💎 Insight — what this means chairside
The honest framing is delay, not cure
Better pocket depths and less bleeding at three months in a disease measured in years of bone loss is a soft-tissue result.
It may buy time or improve conditions before surgery; it is not shown to change the trajectory of the implant.
Better pocket depths and less bleeding at three months in a disease measured in years of bone loss is a soft-tissue result.
It may buy time or improve conditions before surgery; it is not shown to change the trajectory of the implant.
The microbiological effect faded between weeks 8 and 12
That is the pattern you would expect from a locally delivered antibiotic without a change in the underlying biofilm environment.
It argues against thinking of this as a durable microbiological reset.
That is the pattern you would expect from a locally delivered antibiotic without a change in the underlying biofilm environment.
It argues against thinking of this as a durable microbiological reset.
Patients did not feel a difference
Quality of life did not differ, despite the clinical numbers moving.
Worth saying out loud when you are proposing an extra four visits and an extra cost.
Quality of life did not differ, despite the clinical numbers moving.
Worth saying out loud when you are proposing an extra four visits and an extra cost.
⚠️ The catch
Forty-six patients, twelve weeks, single-blind
Small, short, and only single-blinded, in a condition whose outcomes are measured in radiographic bone level over years.
The authors explicitly warn against drawing structural conclusions from the radiographs.
Small, short, and only single-blinded, in a condition whose outcomes are measured in radiographic bone level over years.
The authors explicitly warn against drawing structural conclusions from the radiographs.
Four appointments in three weeks
Baseline plus weeks 1, 2 and 3 is a demanding protocol for a modest, short-lived benefit.
Adherence in ordinary practice will not look like adherence in a trial.
Baseline plus weeks 1, 2 and 3 is a demanding protocol for a modest, short-lived benefit.
Adherence in ordinary practice will not look like adherence in a trial.
Antibiotic use for a soft-tissue endpoint
Repeated local antibiotic application to achieve a bleeding-on-probing improvement deserves the same stewardship scrutiny as any other antibiotic decision.
Repeated local antibiotic application to achieve a bleeding-on-probing improvement deserves the same stewardship scrutiny as any other antibiotic decision.
⚡ Bottom line
- Non-surgical peri-implantitis management → local minocycline gave better 12-week pocket depths and bleeding.
- Hoping to avoid surgery → nothing here shows that. Bone outcomes were not assessable.
- Counselling the patient → they did not report feeling better; the difference was in your measurements.
- Advanced bone loss → this is an adjunct to debridement, not an alternative to surgical management.
🧪 Questions
Tap an answer — instant grade, deciding line, and the trap.
A 61-year-old has peri-implantitis at a lower molar implant with 6 mm probing depths, bleeding on probing, suppuration, and 3 mm of radiographic bone loss. You plan non-surgical debridement. Based on the 2026 multicentre trial, what can you accurately tell the patient about adding local 2% minocycline?
Deciding line: the trial found better adjusted probing depths and less bleeding at 12 weeks while the authors explicitly cautioned that the follow-up was too short to support conclusions about structural stability. Trap: promising avoided surgery is the engineered trap because it is what the patient wants to hear and what a soft-tissue improvement can be mistaken for; the quality-of-life option inverts a specifically negative finding, since patient-reported outcomes did not differ.